The Clorox Company (NYSE:CLX) Position Trimmed by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. lessened its holdings in shares of The Clorox Company (NYSE:CLX) by 18.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,559 shares of the company’s stock after selling 800 shares during the quarter. GHP Investment Advisors Inc.’s holdings in Clorox were worth $508,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Norges Bank bought a new stake in shares of Clorox in the 4th quarter valued at approximately $101,609,000. Imprint Wealth LLC grew its stake in shares of Clorox by 16,986.8% in the 2nd quarter. Imprint Wealth LLC now owns 551,392 shares of the company’s stock valued at $55,139,000 after buying an additional 548,165 shares in the last quarter. Qube Research & Technologies Ltd grew its stake in shares of Clorox by 75.9% in the 3rd quarter. Qube Research & Technologies Ltd now owns 1,130,481 shares of the company’s stock valued at $148,161,000 after buying an additional 487,974 shares in the last quarter. International Assets Investment Management LLC grew its stake in shares of Clorox by 17,658.5% in the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after buying an additional 481,725 shares in the last quarter. Finally, Acadian Asset Management LLC grew its stake in shares of Clorox by 39.6% in the 3rd quarter. Acadian Asset Management LLC now owns 1,467,713 shares of the company’s stock valued at $192,319,000 after buying an additional 415,999 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of NYSE CLX opened at $141.98 on Friday. The business has a fifty day simple moving average of $151.19 and a 200 day simple moving average of $141.36. The Clorox Company has a one year low of $114.68 and a one year high of $178.21. The firm has a market capitalization of $17.62 billion, a price-to-earnings ratio of 225.37, a PEG ratio of 2.25 and a beta of 0.43. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The firm had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the prior year, the business posted $0.98 earnings per share. The business’s revenue was up 16.0% compared to the same quarter last year. Sell-side analysts expect that The Clorox Company will post 5.52 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a yield of 3.38%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is 761.92%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on CLX shares. Morgan Stanley reissued an “equal weight” rating and issued a $160.00 price target on shares of Clorox in a research note on Tuesday, March 26th. The Goldman Sachs Group assumed coverage on Clorox in a report on Friday, March 1st. They issued a “sell” rating and a $140.00 target price for the company. UBS Group upped their price target on Clorox from $145.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, February 2nd. Bank of America upgraded Clorox from an “underperform” rating to a “neutral” rating and upped their price target for the stock from $120.00 to $150.00 in a report on Friday, December 15th. Finally, Citigroup reiterated a “neutral” rating and set a $165.00 price target (down from $170.00) on shares of Clorox in a report on Tuesday, April 2nd. Four equities research analysts have rated the stock with a sell rating and twelve have given a hold rating to the stock. According to MarketBeat, Clorox has a consensus rating of “Hold” and an average target price of $149.13.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.